Indian investors have a new public offering to watch as Capillary Technologies has announced the details of its highly anticipated initial public offering. The company has fixed the price band for its equity shares, setting the stage for one of the notable IPOs in the technology sector.
IPO Pricing and Key Details
The Capillary Technologies India IPO price band has been set between ₹549 and ₹577 per equity share, with each share having a face value of ₹2. This pricing positions the company in the mid-range segment of the market, making it accessible to a broad spectrum of investors.
The lot size for the public offering has been established at 25 equity shares, with investors required to apply in multiples of 25 shares thereafter. This structure allows for flexible investment amounts while maintaining orderly trading patterns post-listing.
Important Dates and Timeline
The subscription window for the Capillary Technologies IPO opens on Friday, November 14, 2025, and will close on Tuesday, November 18, 2025. This gives investors a five-day window to participate in the public offering.
Prior to the public subscription, anchor investors will have their allocation day on Thursday, November 13, 2025. The company will finalize the basis of allotment on Wednesday, November 19, 2025, with refunds initiated the following day on Thursday, November 20, 2025.
The most crucial date for investors is Friday, November 21, 2025, when Capillary Technologies shares are scheduled to be listed on both BSE and NSE. On this same day, the shares will be credited to the demat accounts of successful allottees.
Investor Allocation Structure
The company has implemented a structured allocation policy to ensure balanced participation across different investor categories. Not more than 75% of the shares in the public issue are reserved for qualified institutional buyers (QIB), demonstrating the company's focus on attracting institutional confidence.
Non-institutional investors (NII) have been allocated up to 15% of the offering, while retail investors, who form the backbone of the Indian equity market, have been reserved not more than 10% of the total shares available in the public issue.
This allocation strategy balances the need for institutional support with opportunities for individual investors to participate in the company's growth story through the public markets.
